A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Airway Mucus Hypersecretion

NCT06820749 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

309

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma Bronchiale
Bronchiectasis
Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: HSK31858
DRUG: Placebo

Sponsor

Haisco Pharmaceutical Group Co., Ltd.